AIMC Topic: Calcitonin Gene-Related Peptide Receptor Antagonists

Clear Filters Showing 1 to 2 of 2 articles

Patterns of calcitonin gene-related peptide monoclonal antibody use in people with migraine: Results of the OVERCOME (US) study.

Cephalalgia : an international journal of headache Jun 12, 2025
BackgroundUnderstanding characteristics and reasons associated with using calcitonin gene-related peptide monoclonal antibodies (CGRP mAb) for migraine prevention may help clinicians individualize treatment plans and achieve better patient outcomes.M...
Humans Female Adult Male Middle Aged Cohort Studies United States Migraine Disorders Antibodies, Monoclonal Calcitonin Gene-Related Peptide Calcitonin Gene-Related Peptide Receptor Antagonists
View on PubMed DOI

An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine.

Cephalalgia : an international journal of headache Dec 1, 2024
BACKGROUND: The present study aimed to determine whether machine-learning (ML)-based models can predict 3-, 6, and 12-month responses to the monoclonal antibodies (mAbs) against the calcitonin gene-related peptide (CGRP) or its receptor (anti-CGRPmAb...
Humans Machine Learning Algorithms Prospective Studies Female Adult Male Middle Aged Cohort Studies Treatment Outcome Migraine Disorders Antibodies, Monoclonal Calcitonin Gene-Related Peptide Calcitonin Gene-Related Peptide Receptor Antagonists
View on PubMed DOI
Popular Topics
Recent Journals